Berger knew that Abbott was not active. They had discontinued their fees so how active could they be? His number one concern was to fund the company so it can remain in business and have a chance to prosper. The Paulson stock secondary should take place next week. This will be the start of the rebirth of BioCurex. Berger is a pro and will make Bocx hum.
Market Data 
Markets 
AI
